The Immunologic Effect of Early Intravenous Two and Four Gram Bolus Dosing of Tranexamic Acid Compared to Placebo in Patients With Severe Traumatic Bleeding (TAMPITI): A Randomized, Double-Blind, Placebo-Controlled, Single-Center TrialPhilip C. Spinella, Anja Fuchs, Stacey Reese et al.|Frontiers in Immunology|2020Cited by 42
The risk of thromboembolic events with early intravenous 2‐ and 4‐g bolus dosing of tranexamic acid compared to placebo in patients with severe traumatic bleeding: A secondary analysis of a randomized, double‐blind, placebo‐controlled, single‐center trialPhilip C. Spinella, Grant V. Bochicchio, Kimberly A. Thomas et al.|Transfusion|2022Cited by 27
Trauma patients have reduced ex vivo flow-dependent platelet hemostatic capacity in a microfluidic model of vessel injuryKimberly A. Thomas, Susan M. Shea, Philip C. Spinella et al.|PLoS ONE|2024Cited by 7